Click here to view online. Add this email to your safelist.

AstraZeneca logo

AstraZeneca presents new data across continuum of care from its broad renal portfolio at ERA-EDTA 2020 Virtual Congress

5 June 2020

AstraZeneca will present new data across its broad portfolio of renal medicines during the 57th European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Congress, 6 to 9 June 2020.

The 20 abstracts being presented, including four oral presentations, will include data on Lokelma (sodium zirconium cyclosilicate), roxadustat and Farxiga (dapagliflozin) across different stages of chronic kidney disease (CKD) and AstraZeneca’s ongoing commitment to exploring treatment options across the full continuum of renal care.

Read more  Read more

RSS Feed  RSS Feed Twitter  Follow us on Twitter LinkedIn  Follow us on LinkedIn
Legal notice and Terms of Use Privacy policy Cookie policy Site map © AstraZeneca 2020

For more information please visit astrazeneca.com.

If you would like to unsubscribe please click here.